Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LIFE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for aTyr Pharma stock after losing 1.88%
(Updated on Apr 30, 2024)

Sell candidate since Apr 24, 2024 Loss -1.88% PDF

The aTyr Pharma stock price fell by -1.88% on the last day (Tuesday, 30th Apr 2024) from $1.60 to $1.57. During the last trading day the stock fluctuated 2.88% from a day low at $1.56 to a day high of $1.61. The price has fallen in 7 of the last 10 days and is down by -2.48% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -538 thousand shares and in total, 247 thousand shares were bought and sold for approximately $387.04 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.48 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.56% during the next 3 months and, with a 90% probability hold a price between $1.36 and $1.77 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LIFE Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The aTyr Pharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.60 and $1.77. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Thursday, March 21, 2024 and based on theory for this formation the price should fall by -14.21% to $1.35 within 23 trading days since signal was issued (Wednesday, May 01, 2024).

Support, Risk & Stop-loss for aTyr Pharma stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0450 between high and low, or 2.88%. For the last week the stock has had daily average volatility of 3.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LIFE) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect aTyr Pharma to open at $1.58, and during the day (based on 14 day Average True Range), to move between $1.48 and $1.66, which gives a possible trading interval of +/-$0.0890 (+/-5.67%) up or down from last closing price. If aTyr Pharma takes out the full calculated possible swing range there will be an estimated 11.34% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.60, some $0.0300 (1.91%) from the current price of $1.57, our system finds the risk reward not very attractive.

Is aTyr Pharma stock A Buy?

aTyr Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.027 Sell Candidate Unchanged

Predicted Opening Price for aTyr Pharma of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$1.58 ( 0.531%) $1.57

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LIFE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.62 3.40 %
R2 1.61 2.30 %
R1 1.60 1.63 %
Current price: 1.57
Support S1 1.56 -0.564 %
S2 1.55 -1.24 %
S3 1.53 -2.34 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.91 21.66 %
R2 1.88 19.75 %
R1 1.60 1.91 %
Current price 1.57
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for aTyr Pharma Stock and on which exchange is it traded?
The symbol for aTyr Pharma is LIFE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell aTyr Pharma Stock?
aTyr Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy aTyr Pharma Stock?
aTyr Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy aTyr Pharma Stock.

What's the current price of aTyr Pharma Stock?
As of the end of day on the Apr 30, 2024, the price of an aTyr Pharma (LIFE) share was $1.57.

What is the 52-week high and low for aTyr Pharma Stock?
The 52-week high for aTyr Pharma Stock is $2.70 and the 52-week low is $1.08.

What is the market capitalization of aTyr Pharma Stock?
As of the Apr 30, 2024, the market capitalization of aTyr Pharma is 108.4M.

When is the next earnings date for aTyr Pharma?
The upcoming earnings date for aTyr Pharma is May 14, 2024.
Click to get the best stock tips daily for free!

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and ... LIFE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT